---
$id: https://graph.org.ai/products/commodity/51112013
$type: Product
source: UNSPSC
code: "51112013"
title: "Dasatinib hydrate"
class: "51112000"
classTitle: "Tyrosine kinase inhibitors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dasatinib hydrate

**UNSPSC Code**: 51112013
**Class**: [Tyrosine kinase inhibitors](Tyrosine kinase inhibitors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a tyrosine kinase inhibitor with the molecular formula C22H26ClN7O2S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RBZ1571X5H, chemically known as 5-thiazolecarboxamide, n-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)- but more generally known as dasatinib, which bears US NIH Compound Identifier 3062316. European Medicines Agency schedules Dasatinib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23322. World Health Organization schedules dasatinib in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule dasatinib hydrate under HS 29341000. SMILES: CC1CCCC(C1NC(=O)C2CNC(S2)NC3CC(NC(N3)C)N4CCN(CC4)CCO)CL.O.

